Current and historical daily PE Ratio for XCUR (
Exicure Inc
) from 2018 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Exicure stock (XCUR) PE ratio as of May 28 2024 is 0.19.
More Details
Exicure Inc (XCUR) PE Ratio (TTM) Chart
Exicure Inc (XCUR) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1237
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Exicure PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | 0.2 | 2024-03-22 | 0.3 |
| 2024-05-24 | 0.2 | 2024-03-21 | 0.3 |
| 2024-05-23 | 0.2 | 2024-03-20 | 0.3 |
| 2024-05-22 | 0.2 | 2024-03-19 | 0.3 |
| 2024-05-21 | 0.2 | 2024-03-18 | 0.3 |
| 2024-05-20 | 0.2 | 2024-03-15 | 0.3 |
| 2024-05-17 | 0.2 | 2024-03-14 | 0.3 |
| 2024-05-16 | 0.3 | 2024-03-13 | 0.3 |
| 2024-05-15 | 0.2 | 2024-03-12 | 0.3 |
| 2024-05-14 | 0.2 | 2024-03-11 | 0.3 |
| 2024-05-13 | 0.2 | 2024-03-08 | 0.3 |
| 2024-05-10 | 0.2 | 2024-03-07 | 0.3 |
| 2024-05-09 | 0.2 | 2024-03-06 | 0.3 |
| 2024-05-08 | 0.2 | 2024-03-05 | 0.3 |
| 2024-05-07 | 0.2 | 2024-03-04 | 0.3 |
| 2024-05-06 | 0.2 | 2024-03-01 | 0.3 |
| 2024-05-03 | 0.2 | 2024-02-29 | 0.3 |
| 2024-05-02 | 0.2 | 2024-02-28 | 0.3 |
| 2024-05-01 | 0.2 | 2024-02-27 | 0.3 |
| 2024-04-30 | 0.2 | 2024-02-26 | 0.3 |
| 2024-04-29 | 0.2 | 2024-02-23 | 0.3 |
| 2024-04-26 | 0.2 | 2024-02-22 | 0.3 |
| 2024-04-25 | 0.2 | 2024-02-21 | 0.3 |
| 2024-04-24 | 0.2 | 2024-02-20 | 0.3 |
| 2024-04-23 | 0.3 | 2024-02-16 | 0.3 |
| 2024-04-22 | 0.3 | 2024-02-15 | 0.3 |
| 2024-04-19 | 0.3 | 2024-02-14 | 0.3 |
| 2024-04-18 | 0.3 | 2024-02-13 | 0.3 |
| 2024-04-17 | 0.3 | 2024-02-12 | 0.3 |
| 2024-04-16 | 0.3 | 2024-02-09 | 0.3 |
| 2024-04-15 | 0.3 | 2024-02-08 | 0.3 |
| 2024-04-12 | 0.3 | 2024-02-07 | 0.3 |
| 2024-04-11 | 0.3 | 2024-02-06 | 0.3 |
| 2024-04-10 | 0.3 | 2024-02-05 | 0.3 |
| 2024-04-09 | 0.3 | 2024-02-02 | 0.3 |
| 2024-04-08 | 0.3 | 2024-02-01 | 0.3 |
| 2024-04-05 | 0.3 | 2024-01-31 | 0.3 |
| 2024-04-04 | 0.3 | 2024-01-30 | 0.3 |
| 2024-04-03 | 0.3 | 2024-01-29 | 0.3 |
| 2024-04-02 | 0.3 | 2024-01-26 | 0.3 |
| 2024-04-01 | 0.3 | 2024-01-25 | 0.3 |
| 2024-03-28 | 0.3 | 2024-01-24 | 0.3 |
| 2024-03-27 | 0.3 | 2024-01-23 | 0.3 |
| 2024-03-26 | 0.3 | 2024-01-22 | 0.3 |
| 2024-03-25 | 0.3 | 2024-01-19 | 0.3 |
Exicure Inc (XCUR) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Exicure Inc
NAICS : 325411
SIC : 2834
ISIN : US30205M1018
Description
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers